Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells

Table 1

Details of 10 SLE patients.

Patient	Age	Disease duration	Current treated	SLEDAI
1	21	1 year	Pred 15mg/day	10
			HCQ 0.2g/day
2	18	9 months	Pred 15mg/day	14
			HCQ 0.2g/day
			LEF 0.2g/day
3	24	2 years	Pred 15mg/day	9
			HCQ 0.2g/day
4	28	1 year	Pred 15mg/day	12
			HCQ 0.2g/day
5	24	2 years	Pred 10mg/day	14
			HCQ 0.2g/day
			CTX 0.4g/2 weeks
6	32	3 years	Pred 15mg/day	12
			HCQ 0.2g/day
7	43	6 years	Pred 10mg/day	9
			HCQ 0.2g/day
8	21	4 days	none	13
9	26	1 month	Pred 12.5mg/day	14
			HCQ 0.2g/day
10	32	1 year	Pred 20mg/day	21
			HCQ 0.2g/day
			CTX 0.4g/2 weeks

Pred: prednisolone, HCQ: hydroxychloroquine.
LEF: leflunomide, CTX: cyclophosphamide.